Performing an analytical validation for a next-generation sequencing workflow: A Q&A session with Liverpool Clinical Laboratories
04/09/2024 |
Education
Recently, Thermo Fisher Scientific sat down with Carolina Felix, Senior Biomedical Scientist at the Liverpool Clinical Laboratories (LCL) Molecular...
-
Fusion detection in precision oncology, tradeoff decisions and genomic profiling democratization - An Interview with Dr. Eric Vail
Dr. Eric Vail is Director of Molecular Pathology, Cedars-Sinai Medical Center, Los Angeles, Californ... -
Leveraging Rapid NGS to Advance Hemato-Oncology Research
In a recent Association for Molecular Pathology (AMP) workshop, Dr. Cecilia Yeung shared how her lab... -
How to take advantage of the Oncomine Clinical Research Grant Program
What is the Oncomine Clinical Research Grant Program? The Oncomine Clinical Research Grant is a Ther... -
Improving Patient Access to Homologous Recombination Deficiency Testing for Precision Oncology
Introduction While next-generation sequencing (NGS) has enabled molecular characterization of tumors... -
Simplifying MDS Testing with Next-Generation Sequencing (NGS)
Myelodysplastic syndromes (MDS) are a heterogenous group of myeloid clonal disorders that are charac... -
Comprehensive Genomic Profiling (CGP): Accelerating Progress in Precision oncology
Comprehensive genomic profiling (CGP) is one of the latest innovations in next-generation sequencing... -
Genomic Profiling from Initial Assessment to Detection of Measurable Residual Disease (MRD): How NGS Can Rapidly Deliver Key Insights for Myeloid Neoplasms
In his recent webinar, Dr. Bevan Tandon makes a compelling case for how next-generation sequencing (... -
Next-Generation Sequencing (NGS) for Clonality Testing
Lymphoproliferative disorders such as acute lymphoblastic leukemia (ALL), lymphomas, and multiple my... -
Using Next-Generation Sequencing (NGS) to Derive Key Insights in MPN Testing
Myeloproliferative neoplasms (MPNs) are a heterogeneous group of disorders that include essential th...